Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing ...

Medera announced that updated results from its ongoing MUSIC-HFpEF Phase 1/2a clinical trial investigating SRD-002, a one-time gene therapy ...

Choose from Medical Infusion Illustration stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection ...

AstraZeneca has vowed to spend over $10 billion on R&D deals in Asia, focusing on China, amid ongoing fraud scandal ...

Choose from Iv Drip Patient stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...

The study, led by Professor Zhao Yongxiang, director of the State Key Laboratory of Targeting Oncology, Guangxi Medical University ... no symptoms in humans, as a vector the scientists inserted ...

The one-time therapy, given via an intravenous, or into-the-vein, infusion, was marketed by Pfizer ... The therapy’s recommended dose was 5×10 11 vector genomes per kilogram of body weight (vg/kg), ...

Now, according to research published in Environment & Health, these bits of plastic—from 1 to 62 micrometers long—are present in the filtered solutions used for medical intravenous (IV ...

Now, according to research published in the ACS partner journal Environment & Health, these bits of plastic — from 1 to 62 micrometers long — are present in the filtered solutions used for medical ...